Literature DB >> 6882292

Plasma phosphatidylcholine/free cholesterol ratio as an indicator for atherosclerosis.

A Kuksis, A Roberts, J S Thompson, J J Myher, K Geher.   

Abstract

Plasma lipid profiles were determined in two inbred strains of mice, C57BR/cdJ and CBA/J, fed either a normal chow or an atherogenic diet for a 15-week period, starting at 10 weeks of age. On the chow diet, the C57BR/cdJ had significantly higher mean free cholesterol, esterified cholesterol, and total lipid values, and a significantly lower mean phosphatidylcholine/free cholesterol ratio than the CBA/J mice. On the atherogenic diet, the C57BR/cdJ had significantly higher mean levels for all lipids classes, except triacylglycerols, than the CBA/J mice. The mean plasma free cholesterol and esterified cholesterol levels of the C57BR/cdJ were four times greater than those of the CBA/J strain on the atherogenic diet. The mean plasma phosphatidylcholine/free cholesterol ratio of the C57BR/cdJ mice on the high cholesterol diet was 0.87 compared to 1.91 for CBA/J mice. These plasma lipid changes were associated with a marked development of atheromatous deposits in the wall of the aortic sinus of the C57BR/cdJ compared to the CBA/J animals. The phosphatidylcholine/free cholesterol ratios of the liver lipids of both strains decreased from 2.5-2.7 on the chow diet to 1.0-1.1 on the high cholesterol diet. It is suggested that a plasma phosphatidylcholine/free cholesterol ratio less than 1 represents a supersaturation of the vascular system and the vessel wall with cholesterol, which leads to a destabilization of the plasma membranes of the endothelial and smooth muscle cells, and an infiltration of the vessel wall by the plasma lipids.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6882292     DOI: 10.1161/01.atv.3.4.389

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  9 in total

Review 1.  Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias.

Authors: 
Journal:  CMAJ       Date:  1990-06-15       Impact factor: 8.262

2.  Mg deficiency results in modulation of serum lipids, glutathione, and NO synthase isozyme activation in cardiovascular tissues: relevance to de novo synthesis of ceramide, serum Mg and atherogenesis.

Authors:  Nilank C Shah; Jian-Ping Liu; Jahangir Iqbal; Mahmood Hussain; Xian-Cheng Jiang; Zhiqiang Li; Yan Li; Tao Zheng; Wenyan Li; Anthony C Sica; Jose Luis Perez-Albela; Bella T Altura; Burton M Altura
Journal:  Int J Clin Exp Med       Date:  2011-04-05

3.  Disturbed flow induces systemic changes in metabolites in mouse plasma: a metabolomics study using ApoE⁻/⁻ mice with partial carotid ligation.

Authors:  Young-Mi Go; Chan Woo Kim; Douglas I Walker; Dong Won Kang; Sandeep Kumar; Michael Orr; Karan Uppal; Arshed A Quyyumi; Hanjoong Jo; Dean P Jones
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-11-05       Impact factor: 3.619

4.  Lipid composition of platelets from patients with atherosclerosis: effect of purified eicosapentaenoic acid ethyl ester administration.

Authors:  H Kamido; Y Matsuzawa; S Tarui
Journal:  Lipids       Date:  1988-10       Impact factor: 1.880

5.  Regulation of polyunsaturated fat induced postprandial hypercholesterolemia by a novel gene Phc-2.

Authors:  D S Vaithilingam; V Antao; G Kakis
Journal:  Mol Cell Biochem       Date:  1994-01-12       Impact factor: 3.396

6.  Genetic analysis of murine strains C57BL/6J and C3H/HeJ to confirm the map position of Ath-1, a gene determining atherosclerosis susceptibility.

Authors:  B Paigen; D Albee; P A Holmes; D Mitchell
Journal:  Biochem Genet       Date:  1987-08       Impact factor: 1.890

7.  Influence of a ketogenic diet, fish-oil, and calorie restriction on plasma metabolites and lipids in C57BL/6J mice.

Authors:  Joshua J Meidenbauer; Nathan Ta; Thomas N Seyfried
Journal:  Nutr Metab (Lond)       Date:  2014-05-22       Impact factor: 4.169

8.  Central retinal vein occlusion in a pediatric patient with SLE and antiphospholipid antibodies without anti-cardiolipin or anti-β2 glycoprotein I antibodies.

Authors:  Seigo Korematsu; Hironori Goto; Chika Gotoh; Ryoko Ohki; Toshiaki Kubota; Tatsuro Izumi
Journal:  BMC Pediatr       Date:  2014-05-03       Impact factor: 2.125

9.  NMR Methods for Determining Lipid Turnover via Stable Isotope Resolved Metabolomics.

Authors:  Penghui Lin; Li Dai; Daniel R Crooks; Leonard M Neckers; Richard M Higashi; Teresa W-M Fan; Andrew N Lane
Journal:  Metabolites       Date:  2021-03-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.